Neuro-hormonal regulation of aqueous humor dynamics as the basis of glaucoma pharmacotherapy. Part II - Aqueous humor outflow;Nieurohormonalna regulacja dynamiki cieczy wodnistej jako podstawa farmakoterapii jaskry. Cześć II - Odpływ cieczy wodnistej

Klinika Oczna

Volumn 109, Issue 1-3, 2007, Pages 64-67

  Terelak Borys, Barbara ^a   Liberek, Iwona ^a  

^a MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

Author keywords

Aqueous humor dynamics; Conventional outflow; Parasympathicomimetics; Pharmacotherapy of glaucoma; Prostaglandin analogues; Uveoscleral outflow

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; CHOLINERGIC RECEPTOR STIMULATING AGENT; PROSTAGLANDIN DERIVATIVE;

AQUEOUS HUMOR; AUTONOMIC NERVOUS SYSTEM; DRUG EFFECT; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; METABOLISM; REVIEW; SECRETION;

AQUEOUS HUMOR; AUTONOMIC NERVOUS SYSTEM; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; NEUROTRANSMITTER AGENTS; PARASYMPATHOMIMETICS; PROSTAGLANDINS, SYNTHETIC;

EID: 34447526108     PISSN: 00232157     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Wierzbowska J., Stankiewicz A.: Teoretyczne i kliniczne aspekty zastosowania prostaglandyn w leczeniu jaskry. Klin. Oczna, 2004, 106, 352-359.
2. Nilsson S.F.E., Bill A.: Physiology and neurophysiology of aqueous humor inflow and outflow (w): Textbook of Ophthalmology, 1994, vol.7 - Glaucoma: 1.17-1.34.
3. Wiederholt M.: New aspects in aqueous humor dynamics. (w): Pharmacotherapy of glaucoma, Hans Huber, Bern, 2000, 65-72.
4. Haefliger I.O., Fleischhauer J., Flammer J.: Pharmacological mechanisms of action of drugs commonly used to treat glaucoma patients, (w): Pharmacotherapy of glaucoma, Hans Huber, Bern, 2000, 17-24.
5. Bron A.J., Chidlow G., Melena J., Osborne N.N.: Beta-blockers in the treatment of glaucoma. (w): Pharmacotherapy of glaucoma, Hans Huber, Bern, 2000, 79-114.
6. 2+ transients in cultured bovine trabecular cells. Invest. Ophthalmol. Vis. Sci., 1992, 33, 1676-1684.
7. Flammer J.: Endothelin in the pathogenesis of glaucoma. (w): Vascular risk factors and neuroprotection in glaucoma - update 1996. Kugler Publications Amsterdam/ New York 1997, 97-104.
8. Erickson-Lamy K., Korbmacher C., Schuman J.S., Nathanson J.A.: Effect of endothelin on outflow facility and accomodation in the mon-key eye in vivo. Invest. Ophthalmol. Vis. Sci., 1991, 32, 492-495.
9. Schmidt K.G.: Prostaglandin receptors in ocular tissues and their pharmacological influence. (w): Pharmacotherapy of glaucoma, Hans Huber, Bern, 2000, 159-168.
10. Kaufman P.L., Gabelt B.A.: α-2 adrenergic agonist effect on aqueous humor dynamics. J. Glaucoma, 1995, 4, Suppl. 1, 8-14.
11. Drewe J.: Lipids and glaucoma. (w): Glaucoma therapy - current issues and controversies, Martin Dunitz, Londyn, 2004, 61-68.
12. Larsson L.-I., Alm A.: Clinical aspects of uveoscleral outflow. (w): Uveoscleral outflow. Biology and clinical aspects. Mosby-Wolfe Medical Communication, Barcelona, 1998, 73-86.